Plasma galectin-9 levels in AL-MDS patients were significantly elevated in comparison with those in patients with refractory anemia (RA) and RAEB (P = 0.0051 and P = 0.0013, respectively; Figure 5B). This evidence concerns the gene LGALS9 and myelodysplastic syndrome with single lineage dysplasia.